Actuate Therapeutics Inc (ACTU) Annual Balance Sheets

Annual · GAAP · USD millions
Access ACTU quarterly Balance Sheets →
Tracking balance sheet results across Actuate Therapeutics Inc to helps illustrate how Dec 31 2025's financial position has responded to changing business conditions.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024)
Assets
Cash & cash equivalent13.16
Cash & Short-term Investments13.00
Prepaid Expense And Other Assets Current0.48
Total Current Assets13.64
Other Assets, Noncurrent0.39
Total Assets14.04
Liabilities
Accounts Payable, Current AC1.52
Accrued Liabilities, Current4.16
Other Liabilities, Current0.03
Total Current Liabilities5.71
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
License Payable Noncurrent0.40
Total Liabilities6.11
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock162.53
Retained Earnings / Accumulated Deficit-154.61
Other Equity0.00
Common Stockholder's Equity7.92
Total Stockholder's Equity7.92
Liabilities & Stockholder's Equity14.04
4 historic quarters locked

Sign in to unlock the full Actuate Therapeutics Inc balance sheet history.

About Actuate Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001683168-26-002257

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License